Onkure Therapeutics - Class A (OKUR) closed at $2.62 on October 30, 2026, unchanged from the previous close, on volume of 303,391 shares (30-day average 388,396).
Data as of October 30, 2026.
30-Oct-2026
Russell 2000 estimated to drop 83 stocks in December rebalance - Stephens
Seeking Alpha News (Thu, 29-Oct 3:44 PM ET)
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
Globe Newswire (Mon, 31-Aug 8:00 AM ET)
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
Globe Newswire (Tue, 4-Aug 4:05 PM ET)
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Ka. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.
As of October 30, 2026, OKUR stock price was flat at $2.62 with 303,391 million shares trading.
OKUR has a beta of 1.50, meaning it tends to be more sensitive to market movements. OKUR has a correlation of 0.06 to the broad based SPY ETF.
OKUR has a market cap of $106.10 million. This is considered a Micro Cap stock.
Last quarter Onkure Therapeutics - Class A reported $0 in Revenue and -$.31 earnings per share. This fell short of revenue expectation by $-200,000 and exceeded earnings estimates by $.31.
The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
OKUR has underperformed the market in the last year with a return of -21.8%, while the SPY ETF gained +12.3%. In the last 3 month period, OKUR fell short of the market, returning -34.5%, while SPY returned +2.1%. However, in the most recent 2 weeks OKUR has outperformed the stock market by returning +24.8%, while SPY returned -1.0%.
OKUR support price is $2.47 and resistance is $2.77 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.
